Dihexa vs Semax: Literature and Handling Compared
Dihexa and Semax appear together in search far more often than they appear together in published methodology. That gap is the useful part.
Compound profiles
Dihexa in the indexed record
Dihexa returns 17 indexed records on PubMed, a limited record with no registered studies currently listed on ClinicalTrials.gov.
Recent indexed work appears in Ann Med Surg (Lond), Brain Sci, Front Cell Neurosci, spanning 2007–2026.
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions — J Am Acad Orthop Surg Glob Res Rev, 2026. PMID: 41490200
- AngIV-Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway — Brain Sci, 2021. PMID: 34827486
- Hepatocyte growth factor mimetic protects lateral line hair cells from aminoglycoside exposure — Front Cell Neurosci, 2015. PMID: 25674052
- Stem cell, Granulocyte-Colony Stimulating Factor and/or Dihexa to promote limb function recovery in a rat sciatic nerve damage-repair model: Experimental animal studies — Ann Med Surg (Lond), 2021. PMID: 34703584
Semax in the indexed record
Indexed output for Semax stands at 207 records, a moderate literature with no registered studies currently listed on ClinicalTrials.gov.
Recent indexed work appears in ACS Chem Neurosci, Bioinorg Chem Appl, Br J Pharmacol, spanning 2020–2026.
- Semax peptide targets the μ opioid receptor gene Oprm1 to promote deubiquitination and functional recovery after spinal cord injury in female mice — Br J Pharmacol, 2025. PMID: 40692165
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions — J Am Acad Orthop Surg Glob Res Rev, 2026. PMID: 41490200
- Functional Connectomic Approach to Studying Selank and Semax Effects — Dokl Biol Sci, 2020. PMID: 32342318
- Semax, synthetic ACTH(4-10) analogue, attenuates behavioural and neurochemical alterations following early-life fluvoxamine exposure in white rats — Neuropeptides, 2021. PMID: 33418449
How the literature differs
The indexed record is not symmetrical between these two compounds. Semax carries 190 more indexed records than Dihexa, which means published methodology, characterisation data and replication attempts are more readily located for Semax. For a researcher planning a literature review, that asymmetry usually determines which compound has established reference protocols and which requires primary-source work.
Registered study counts (0 vs 0) track a different signal — formal study registration rather than published output — and the two figures frequently diverge.
Side-by-side research profile
| Parameter | Dihexa | Semax |
|---|---|---|
| PubMed indexed records | 17 | 207 |
| Registered studies (ClinicalTrials.gov) | 0 | 0 |
| Literature depth | Emerging | Moderate |
| Handling class | Lyophilised powder | Lyophilised powder |
| Designation | Research use only | Research use only |
Classification and why it matters
Dihexa and Semax sit in different structural classes, and that classification is what determines whether a published protocol for one has any bearing on the other. Peptide research compounds are grouped by sequence length, origin and the receptor families the literature associates with them — not by the outcome a reader might be looking for.
Reading across classes is the most common error in a literature review. A protocol developed for Dihexa describes conditions validated for Dihexa: concentration ranges, solvent choice, incubation windows and control selection were all established against that compound. Applying those same conditions to Semax without re-validation produces data that cannot be compared back to the source publication.
Where the two compounds are studied in overlapping models, the published work almost always treats them as separate arms rather than as substitutes. That separation is the useful signal: it indicates the research record does not consider them equivalent.
What the paperwork has to show
A certificate of analysis is only meaningful when it names the lot printed on the vial. Purity by HPLC and identity by mass spectrometry answer two different questions, and a document reporting one is not evidence of the other.
Storage and stability
Lyophilised peptide is the stable form. Held sealed at -20°C and shielded from light, it tolerates long storage; once reconstituted that tolerance drops sharply and the working solution is treated as short-lived.
Each freeze-thaw cycle costs integrity, which is why reconstituted material is normally split into single-use aliquots.
Selecting between them for a study design
Dihexa and Semax are not interchangeable. They differ in structural class and in the pathways the literature associates with each, so substituting one for the other changes what a model is actually measuring.
Where a protocol cites a specific compound, the cited compound is the one the published result applies to. Where no protocol exists, the compound with the deeper indexed record (Semax) generally offers more methodological precedent.
Frequently asked questions
How should these compounds be stored?
Lyophilised material is conventionally stored at -20°C protected from light. Reconstituted solution is far less stable and is held at 2-8°C for short-duration laboratory work only.
Are Dihexa and Semax the same compound?
No. They are structurally distinct research compounds with separate literature records — 17 indexed records for Dihexa and 207 for Semax.
Which of Dihexa or Semax has more published research?
Semax, with 207 indexed PubMed records against 17.
Related references
- Semax — product and lot documentation
- Certificate of analysis & purity testing
- Research reference index
Research use only. The compounds discussed are supplied for in-vitro laboratory research. They are not drugs, are not approved for the diagnosis, treatment, cure or prevention of any condition, and are not intended for human or veterinary consumption.